BioAtla (BCAB) Asset Utilization Ratio (2021 - 2025)
BioAtla's (BCAB) quarterly Asset Utilization Ratio came in at 1.29 in Q4 2025, up 571.05% year-on-year from 0.19 in Q4 2024, and up 151.88% quarter-over-quarter from 0.51 in Q3 2025.
BioAtla (BCAB) Asset Utilization Ratio (2021 - 2025) Analysis & Trends
BioAtla's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 1.29 for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio rose 571.05% year-over-year to 1.29 in Q4 2025; TTM through Dec 2025 was 1.29, a 571.05% increase from a year earlier, with the FY2025 full-year figure at 0.07, down 44.83% from the prior year.
- Asset Utilization Ratio advanced to 1.29 in Q4 2025 per BCAB's latest filing, from 0.51 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.29 in Q4 2025 and bottomed at 0.0 in Q4 2021.
- The 4-year median for Asset Utilization Ratio is 0.0 (2021), against an average of 0.24.
- Across the five-year window, Asset Utilization Ratio soared 11028.23% in 2024 and surged 204.1% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.0 in 2021, then soared by 60.73% to 0.0 in 2023, then soared by 12602.08% to 0.19 in 2024, then soared by 571.05% to 1.29 in 2025.
- Per Business Quant, the three latest BCAB Asset Utilization Ratio figures stand at 1.29 (Q4 2025), 0.51 (Q3 2025), and 0.19 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.29 |
| Sep 30, 2025 | 0.51 |
| Dec 31, 2024 | 0.19 |
| Sep 30, 2024 | 0.17 |
| Sep 30, 2023 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |